Synergistic inhibition of human T-cell lymphotropic virus type III replication in vitro by phosphonoformate and recombinant alpha-A interferon
- 1 July 1986
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 30 (1), 189-191
- https://doi.org/10.1128/aac.30.1.189
Abstract
Phosphonoformate and recombinant alpha-A interferon synergistically inhibited the replication of human T-cell lymphotropic virus type III in cultured peripheral blood lymphocytes. T-cell proliferative capability was maintained by this combination, and toxicity was minimal.This publication has 17 references indexed in Scilit:
- Detection of human anti‐HTLV‐III antibodies by indirect immunofluorescence using fixed cellsTransfusion, 1985
- INHIBITION OF HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE III IN VITRO BY PHOSPHONOFORMATEThe Lancet, 1985
- RECOMBINANT HUMAN INTERFERON ALFA-A SUPPRESSES HTLV-III REPLICATION IN VITROThe Lancet, 1985
- HTLV-III in the Semen and Blood of a Healthy Homosexual ManScience, 1984
- Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitorsAdvances in Enzyme Regulation, 1984
- An Effect of Interferon on the Uncoating of Murine Leukaemia Virus Not Related to the Antiviral StateJournal of General Virology, 1980
- Effect of Interferon on Murine Leukaemia Virus Infection. IV. Formation of Non-infectious Virus in Chronically Infected CellsJournal of General Virology, 1979
- Interferon inhibits C-type virus at a posttranscriptional, prerelease stepArchiv für die gesamte Virusforschung, 1978
- A Method for Testing for Synergy with Any Number of AgentsThe Journal of Infectious Diseases, 1978
- Effect of interferon on exogenous, endogenous, and chronic murine leukemia virus infectionVirology, 1976